Freestone Capital Holdings’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$269K Hold
25,921
0.01% 380
2025
Q1
$342K Hold
25,921
0.01% 332
2024
Q4
$464K Hold
25,921
0.02% 296
2024
Q3
$418K Buy
25,921
+17,921
+224% +$289K 0.01% 316
2024
Q2
$216K Buy
+8,000
New +$216K 0.01% 424